|
Volumn 21, Issue 2, 2001, Pages 129-136
|
Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis
|
Author keywords
Cirrhosis; Cochrane; Colchicine; Fibrosis; Meta analysis; Randomized, controlled trial; Systematic review
|
Indexed keywords
ALKALOID;
ANTIFIBROTIC AGENT;
ANTIINFLAMMATORY AGENT;
COLCHICINE;
MARKER;
PLACEBO;
ADVERSE DRUG REACTION;
ALCOHOL CONSUMPTION;
ALCOHOL LIVER CIRRHOSIS;
ARTICLE;
CLINICAL TRIAL;
COMPLICATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
EVALUATION;
HEALTH ECONOMICS;
HUMAN;
LANGUAGE;
LETTER;
LIVER CIRRHOSIS;
LIVER DISEASE;
LIVER FIBROSIS;
LIVER HISTOLOGY;
MEDICAL INFORMATION;
MORTALITY;
OUTCOMES RESEARCH;
PUBLICATION;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RISK;
SINGLE BLIND PROCEDURE;
STATISTICS;
ADMINISTRATION, ORAL;
COLCHICINE;
DOUBLE-BLIND METHOD;
HUMANS;
LIVER CIRRHOSIS, ALCOHOLIC;
ODDS RATIO;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
SINGLE-BLIND METHOD;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0035035924
PISSN: 01069543
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1600-0676.2001.021002129.x Document Type: Article |
Times cited : (35)
|
References (41)
|